Search Within

Nursing

Formats
  1. Journal Article (1747)
  2. Meeting Abstract (1582)
  3. Book Section (130)
  4. Review (109)
  5. Editorial (92)
  6. Conference Paper (27)
  7. Research Letter (17)
  8. Book Whole (15)
  9. Miscellaneous (15)
  10. Correspondence (12)
  11. Guidelines (10)
Groups
  1. Department of Medicine (1497)
  2. Advanced Practice Providers (1172)
  3. Survivorship Research (962)
  4. Solid Tumor Oncology Division (884)
  5. Epidemiology and Biostatistics (641)
  6. Hematologic Malignancies, Division of (611)

More Groups

People
  1. William Rosa (235)
  2. Nessa Coyle (123)
  3. Sergio Giralt (117)
  4. Mark Kris (114)
  5. Howard Scher (100)
  6. Andrew Zelenetz (99)

More People

Years
  1. 2026 (7)
  2. 2025 (184)
  3. 2024 (213)
  4. 2023 (195)
  5. 2022 (202)
  6. 2021 (171)

More Years

Publications
  1. Journal of Clinical Oncology (451)
  2. Oncology Nursing Forum (420)
  3. Blood (212)
  4. Clinical Journal of Oncology Nursing (121)
  5. Biology of Blood and Marrow Transplantation (88)
  6. Clinical Cancer Research (71)

More Publications

Publishers
  1. Oncology Nursing Society (ONS) (566)
  2. American Society of Clinical Oncology (492)
  3. Elsevier Inc. (428)
  4. Lippincott Williams & Wilkins (260)
  5. American Society of Hematology (226)
  6. American Association for Cancer Research (158)

More Publishers

Results (3756)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I dose escalation trial of a daily oral CDK 4/6 inhibitor PD-0332991
    Meeting Abstract

    O'Dwyer, P. J.; LoRusso, P.; DeMichele, A.; Gupta, V.; Barbi, A.; Dials, H.; Chen, I.; Courtney, R.; Wilner, K.; Schwartz, G. K.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • How well do we communicate with patients concerning adjuvant systemic therapy? A survey of 150 colorectal cancer survivors
    Meeting Abstract

    Love, N.; Bylund, C.; Meropol, N. J.; Marshall, J. L.; Curley, S. A.; Ellis, L. M.; Grothey, A.; Lenz, H. J.; Saltz, L. B.; Elder, M. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • The implementation of a rapid response team at Memorial Sloan-Kettering Cancer Center: A preliminary report
    Meeting Abstract

    Klotz, A. D.; Thattassery, E.; Graham, D.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel (Tax), IP cisplatin (Cis), and IV bevacizumab (Bev) as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer
    Meeting Abstract

    Konner, J. A.; Fallon, K.; Pezzuli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Chiang, A.; Tew, W.; Spriggs, D.; Aghajanian, C.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I trial of PTK787/ZK222584 (PTK/ZK) in combination with carboplatin (C) and paclitaxel (T) in platinum-sensitive recurrent epithelial ovarian (EOC), fallopian tube (FT), or primary peritoneal (PPC) cancers
    Meeting Abstract

    Juretzka, M. M.; Aghajanian, C.; Hensley, M. L.; Tew, W. P.; Spriggs, D.; Konner, J.; Chiang, A. C.; Pezzulli, S.; Kim, M.; Sabbatini, P.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Initial findings from the Memorial Sloan-Kettering Early Onset and Familial Gastric Cancer Registry (EOFGCR)
    Meeting Abstract

    Harlan, M.; Sheehy, E.; Randazzo, J.; Schrag, D.; Kemeny, M. M.; Kelsen, D. P.; Shah, M. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Feldman, D. R.; Kondagunta, G. V.; Ronnen, E. A.; Fischer, P.; Chang, R.; Baum, M.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Motzer, R. J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Randomized phase II trial of three dosing schedules of nanoparticle albumin-bound paclitaxel with bevacizumab as first-line therapy for HER2-negative metastatic breast cancer: An initial interim safety report
    Meeting Abstract

    Conlin, A. K.; Seidman, A. D.; Moynahan, M. E.; Traina, T.; Mace, J. R.; Meiri, E.; Bach, A.; Edwards, C.; Hudis, C. A.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Pharmacokinetics (PK) of split-dose flavopiridol (F) administered with CPT-11 (CPT) and cisplatin (Cis)
    Meeting Abstract

    Carvajal, R. D.; Tse, A.; Wu, N.; Gonen, M.; Lefkowitz, R.; Dials, H.; Barbi, A.; Mui, J.; Schwartz, G. K.; Shah, M.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • A nomogram predicting survival of patients (pts) with metastatic or unresectable urothelial cancer (UC) treated with cisplatin-based chemotherapy
    Meeting Abstract

    Bajorin, D. F.; Ostrovnaya, I.; Iasonos, A.; Milowsky, M. I.; Boyle, M.; Riches, J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save